K Ravi Acharya

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 43

Top Topics

Structural Basis

Clostridium Difficile

Amyotrophic Lateral Sclerosis

Angiotensin Converting Enzyme

Top Venues

The FEBS journal

Bioscience reports

This page only lists publications with an associated author ORCID identifier.

Publications

Otsile O Mojanaga, Timothy J Woodman, Matthew D Lloyd, K Ravi Acharya
α-Methylacyl-CoA Racemase from Mycobacterium tuberculosis -Detailed Kinetic and Structural Characterization of the Active Site. Biomolecules 14 (3) (2024)
Matthew D Lloyd, Kyle S Gregory, K Ravi Acharya
Functional implications of unusual NOS and SONOS covalent linkages found in proteins. Chemical communications (Cambridge, England) 60 (71) (2024)
Otsile O Mojanaga, Timothy J Woodman, Matthew D Lloyd, K Ravi Acharya
α-Methylacyl-CoA Racemase from Mycobacterium tuberculosis -Detailed Kinetic and Structural Characterization of the Active Site. Biomolecules 14 (3) (2024)
K Ravi Acharya, Kyle S Gregory, Edward D Sturrock
Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors. Bioscience reports 44 (8) (2024)
Matthew D Lloyd, Kyle S Gregory, K Ravi Acharya
Functional implications of unusual NOS and SONOS covalent linkages found in proteins. Chemical communications (Cambridge, England) 60 (71) (2024)
K Ravi Acharya, Kyle S Gregory, Edward D Sturrock
Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors. Bioscience reports 44 (8) (2024)
K Ravi Acharya, Kyle S Gregory, Edward D Sturrock
Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors. Bioscience reports 44 (8) (2024)
Otsile O Mojanaga, Timothy J Woodman, Matthew D Lloyd, K Ravi Acharya
α-Methylacyl-CoA Racemase from Mycobacterium tuberculosis -Detailed Kinetic and Structural Characterization of the Active Site. Biomolecules 14 (3) (2024)
K Ravi Acharya, Kyle S Gregory, Edward D Sturrock
Advances in the structural basis for angiotensin-1 converting enzyme (ACE) inhibitors. Bioscience reports 44 (8) (2024)
Matthew D Lloyd, Kyle S Gregory, K Ravi Acharya
Functional implications of unusual NOS and SONOS covalent linkages found in proteins. Chemical communications (Cambridge, England) (2024)
Kyle S Gregory, K Ravi Acharya
A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins 15 (2) (2023)
Kyle S Gregory, Gyles E Cozier, Sylva L U Schwager, Edward D Sturrock, K Ravi Acharya
Structural insights into the inhibitory mechanism of angiotensin-I converting enzyme by the lactotripeptides IPP and VPP. FEBS letters (2023)
Amelia Barclay, K Ravi Acharya
Engineering Plastic Eating Enzymes Using Structural Biology. Biomolecules 13 (9) (2023)
Kyle S Gregory, K Ravi Acharya
A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins 15 (2) (2023)
Kyle S Gregory, K Ravi Acharya
A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins 15 (2) (2023)
Kyle S Gregory, K Ravi Acharya
A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins 15 (2) (2023)
Kyle S Gregory, K Ravi Acharya
A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins 15 (2) (2023)
Joanna Żukowska, Stephen J Moss, Vasanta Subramanian, K Ravi Acharya
Molecular basis of selective amyloid-β degrading enzymes in Alzheimer's disease. The FEBS journal (2023)
Anna C Lloyd, Kyle S Gregory, R Elwyn Isaac, K Ravi Acharya
A Molecular Analysis of the Aminopeptidase P-Related Domain of PID-5 from Caenorhabditis elegans . Biomolecules 13 (7) (2023)
Kyle S Gregory, Peter-Rory Hall, Jude Prince Onuh, Otsile O Mojanaga, Sai Man Liu, K Ravi Acharya
Crystal Structure of the Catalytic Domain of a Botulinum Neurotoxin Homologue from Enterococcus faecium : Potential Insights into Substrate Recognition. International journal of molecular sciences 24 (16) (2023)
Kyle S Gregory, K Ravi Acharya
A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins 15 (2) (2023)
Kyle S Gregory, Anna R Newell, Otsile O Mojanaga, Sai Man Liu, K Ravi Acharya
Crystal Structures of the Clostridium botulinum Neurotoxin A6 Cell Binding Domain Alone and in Complex with GD1a Reveal Significant Conformational Flexibility. International journal of molecular sciences 23 (17) (2022)
Lauren B Arendse, Gyles E Cozier, Charles J Eyermann, Gregory S Basarab, Sylva L Schwager, Kelly Chibale, K Ravi Acharya, Edward D Sturrock
Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition. Journal of medicinal chemistry 65 (4) (2022)
Gyles E Cozier, Emma C Newby, Sylva L U Schwager, R Elwyn Isaac, Edward D Sturrock, K Ravi Acharya
Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat. The FEBS journal 289 (21) (2022)
Kyle S Gregory, Tejaswini B Mahadeva, Sai Man Liu, K Ravi Acharya
Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain. Toxins 14 (5) (2022)
Kyle S Gregory, Otsile O Mojanaga, Sai Man Liu, K Ravi Acharya
Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside. Toxins 14 (2) (2022)
Samuel L Crine, K Ravi Acharya
Molecular basis of C-mannosylation - a structural perspective. The FEBS journal (2021)
Jonathan R Davies, Amy Britton, Sai Man Liu, K Ravi Acharya
High-resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6. FEBS open bio 10 (8) (2020)
Urvashi Sharma, Gyles E Cozier, Edward D Sturrock, K Ravi Acharya
Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme. Journal of medicinal chemistry 63 (10) (2020)
Gyles E Cozier, K Ravi Acharya
How a DNA mimic catches and cleaves NF-κB. The Journal of biological chemistry 293 (39) (2020)
Gyles E Cozier, Lizelle Lubbe, Edward D Sturrock, K Ravi Acharya
Angiotensin-converting enzyme open for business: structural insights into the subdomain dynamics. The FEBS journal 288 (7) (2020)
Kyle S Gregory, Sai Man Liu, K Ravi Acharya
Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside. FEBS open bio 10 (3) (2020)
Ross Ferguson, Daniel E Holloway, Anand Chandrasekhar, K Ravi Acharya, Vasanta Subramanian
The catalytic activity and secretion of zebrafish RNases are essential for their in vivo function in motor neurons and vasculature. Scientific reports 9 (1) (2019)
Edward D Sturrock, Lizelle Lubbe, Gyles E Cozier, Sylva L U Schwager, Afolake T Arowolo, Lauren B Arendse, Emma Belcher, K Ravi Acharya
Structural basis for the C-domain-selective angiotensin-converting enzyme inhibition by bradykinin-potentiating peptide b (BPPb). The Biochemical journal 476 (10) (2019)
William J Bradshaw, Jean-François Bruxelle, Andrea Kovacs-Simon, Nicholas J Harmer, Claire Janoir, Severine Péchiné, K Ravi Acharya, Stephen Ll Michell
Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen Clostridioides difficile. The Journal of biological chemistry 294 (43) (2019)
Stephen Moss, Vasanta Subramanian, K Ravi Acharya
Crystal structure of peptide-bound neprilysin reveals key binding interactions. FEBS letters 594 (2) (2019)
Shalini Iyer, K Ravi Acharya, Vasanta Subramanian
Prediction of structural consequences for disease causing variants in C21orf2 protein using computational approaches. Journal of biomolecular structure & dynamics 37 (2) (2018)
Gyles E Cozier, Lauren B Arendse, Sylva L Schwager, Edward D Sturrock, K Ravi Acharya
Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design. Journal of medicinal chemistry 61 (22) (2018)
Jonathan R Davies, Sai Man Liu, K Ravi Acharya
Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics. Toxins 10 (10) (2018)
Shalini Iyer, Vasanta Subramanian, K Ravi Acharya
C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor. PeerJ 6 (2018)
Gyles E Cozier, Sylva L Schwager, Rajni K Sharma, Kelly Chibale, Edward D Sturrock, K Ravi Acharya
Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity. The FEBS journal 285 (8) (2018)
William J Bradshaw, Jonathan M Kirby, April K Roberts, Clifford C Shone, K Ravi Acharya
The molecular structure of the glycoside hydrolase domain of Cwp19 from Clostridium difficile. The FEBS journal 284 (24) (2017)
William J Bradshaw, April K Roberts, Clifford C Shone, K Ravi Acharya
The structure of the S-layer of Clostridium difficile. Journal of cell communication and signaling 12 (1) (2017)